Chapter CSB 4
PRESCRIPTION DRUG MONITORING PROGRAM
CSB 4.01 Authority and scope. CSB 4.03 Drugs that have a substantial potential for abuse. CSB 4.04 Compilation of dispensing data. CSB 4.05 Electronic submission of dispensing data. CSB 4.06 Frequency of submissions. CSB 4.07 Correction of dispensing data. CSB 4.08 Exemptions from compiling and submitting dispensing data. CSB 4.09 Access to monitored prescription drug history reports and PDMP data about a patient. CSB 4.093 Monitored prescription drug history reports and audit trails about healthcare professionals. CSB 4.097 Deny, suspend, revoke or otherwise restrict or limit access. CSB 4.10 Requests for review. CSB 4.105 Practitioners’ requirement to review monitored prescription drug history reports. CSB 4.11 Methods of obtaining monitored prescription drug history reports. CSB 4.12 Use of PDMP data by the board and department. CSB 4.13 Confidentiality of PDMP records. CSB 4.14 Exchange of PDMP data. CSB 4.15 Disclosure of suspicious or critically dangerous conduct or practices. CSB 4.01CSB 4.01 Authority and scope. The rules in this chapter are adopted under authority in ss. 227.11 (2) (a) and 961.385, Stats., for the purpose of creating a prescription drug monitoring program to collect and disclose information relating to the prescribing and dispensing of monitored prescription drugs.